Roy Dennis Bloom

faculty photo
Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
One Founders Pavilion
3400 Spruce Street
Philadelphia, Pa 19104-6144
Office: (215) 662-4643
Fax: (215) 615-0349
Education:
BSc (Physiology and Biochemistry)
University of Witwatersrand, 1980.
M.B.B.Ch.
University of Witwatersrand, 1983.
Permanent link
 

Description of Research Expertise

Kidney transplant outcomes, Post-transplant diabetes mellitus, hepatitis C in kidney transplantation

Description of Itmat Expertise

Dr. Bloom engages in clinical outcomes research, particularly pertaining to hepatitis C, transplant associated hyperglycemia and combined liver-kidney transplantation. He also has an active interest in immunosuppressive drug trials, both investigator-initiated and biopharmaceutical-initiated multicenter studies.

Selected Publications

Potluri VS, Bloom RD: Treating Hepatitis C Virus in Patients with Advanced CKD in the Real-World: Time to Refocus on What Our Real Treatment Goals Should Be. Kidney International 94(1): 18-21, July 2018.

Tsai DE, Bagley S, Reshef R, Shaked A, Bloom RD, Ahya V, Goldberg L, Chung A, Debonera F, Schuster SJ, Huntington SF: The changing face of adult posttransplant lymphoproliferative disorder: Changes in histology between 1999 and 2013. American Journal of Hematology 93(7): 874-881, July 2018.

Gumber R, Cohen JB, Palmer MB, Kobrin SM, Vogl DT, Wasserstein AG, Nasta SD, Bleicher MB, Bloom RD, Dember L, Cohen A, Weiss BM, Hogan JJ: A clone-directed approach may improve diagnosis and treatment of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Kidney International 94(1): 199-205, July 2018.

Aufhauser DD Jr, Peng AW, Murken DR, Concors SJ, Abt PL, Sawinski D, Bloom RD, Reese PP, Levine MH. : Impact of prolonged dialysis prior to renal transplantation. Clinical Transplantation 32(6), June 2018.

Varga Alexandra N, Johnson David, Sawinski Deirdre L, Lim Mary Ann, Bloom Roy D, Abt Peter L, Goral Simin, Bleicher Melissa, Levine Matthew H, Naji Ali, Nazarian Susanna, Porrett Paige, Trofe-Clark Jennifer: Safety and Feasibility of Outpatient Rabbit Antithymocyte Globulin Induction Therapy Administration in Kidney Transplant Recipients. Pharmacotherapy Apr 2018.

Axelrod DA, Schnitzler MA, Alhamad T, Gordon F, Bloom RD, Hess GP, Xiao H, Nazzal M, Segev DL, Dharnidharka VR, Naik AS, Lam NN, Ouseph R, Kasiske BL, Durand CM, Lentine KL: The impact of direct-acting antiviral agents on liver and kidney transplant costs and outcomes. American Journal of Transplantation Page: (in press), April 2018.

McCauley M, Mussell A, Goldberg D, Sawinski D, Molina RN, Tomlin R, Doshi SD, Abt P, Bloom R, Blumberg E, Kulkarni S, Esnaola G, Shults J, Thiessen C, Reese PP.: Race, Risk, and Willingness of End-Stage Renal Disease Patients Without Hepatitis C Virus to Accept an HCV-Infected Kidney Transplant. Transplantation 102(4): e163-e170, April 2018.

Lim MA, Kamili S, Cohen JB, Green-Montfort T, Tejada-Strop A, Kohli J, Drobeniuc J, Patel P, Vanderveen M, Bloom RD.: Hepatitis E Virus Infection in Kidney Transplant Patients: A Single-Center Study. Transplantation 102(4): e126-e127, April 2018.

Trofe-Clark J, Brennan DC, West-Thielke P, Milone MC, Lim MA, Neubauer R, Nigro V, Bloom RD: Results of ASERTAA, a Randomized Prospective Crossover Pharmacogenetic Study of Immediate Release Tacrolimus versus Extended Release Tacrolimus in African American Kidney Transplant Recipients American Journal of Kidney Diseases 71(3): 315-326, March 2018.

Reese PP, Abt PL, Blumberg E, Van Deerlin VM, Bloom RD, Potluri VS, Levine M, Porrett P, Sawinski D, Nazarian SM, Naji A, Hasz R, Suplee L, Trofe-Clark J, Sicilia A, McCauley M, Gentile C, Smith J, Niknam BA, Bleicher M, Reddy KR, Goldberg DS : Twelve month outcomes after transplantation of hepatitis-C infected kidneys into uninfected recipients: A single-arm trial. Annals of Internal Medicine (in press) 2018.

back to top
Last updated: 09/24/2018
The Trustees of the University of Pennsylvania